PetMed Express Sales Plunge 20.5% YoY, Customer Adds Fall Sharply
Summary
PetMed Express reported a 20.5% year-over-year sales decline, a more severe contraction than the 16% decline reported yesterday. This significant drop was attributed to lower prescription reorder volume and reduced paid media spend, resulting in new customer additions plummeting from 351,000 to approximately 266,000. The worsening sales performance and customer acquisition challenges highlight deeper operational issues for the company.
At the time of this announcement, PETS was trading at $2.02 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $45.6M. The 52-week trading range was $1.57 to $4.32. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.